Lisa Delfini Trevi Therapeutics, Inc. (TRVI) insider trading activity

TRVI Quotes by TradingView

Lisa Delfini is Chief Financial Officer of Trevi Therapeutics, Inc.. Currently has a direct ownership of 53,279 shares of TRVI, which is worth approximately $215,779. The most recent transaction as insider was on May 22, 2024, when has been sold 4,350 shares (Common Stock) at a price of $2.64 per share, resulting in proceeds of $11,484. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 53.3K
0% 3M change
48.41% 12M change
Total Value Held $215,779

Lisa Delfini Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 22 2024
SELL
Open market or private sale
$11,484 $2.64 p/Share
4,350 Reduced 7.55%
53,279 Common Stock
May 22 2024
BUY
Exercise of conversion of derivative security
$8,181 $0.51 p/Share
16,043 Added 21.78%
57,629 Common Stock
Oct 11 2023
SELL
Open market or private sale
$1,585 $2.02 p/Share
785 Reduced 2.14%
35,901 Common Stock
Oct 11 2023
BUY
Exercise of conversion of derivative security
$1,168 $0.51 p/Share
2,292 Added 5.88%
36,686 Common Stock
Sep 11 2023
SELL
Open market or private sale
$1,564 $2.2 p/Share
711 Reduced 2.03%
34,394 Common Stock
Sep 11 2023
BUY
Exercise of conversion of derivative security
$1,168 $0.51 p/Share
2,291 Added 6.13%
35,105 Common Stock
Aug 11 2023
SELL
Open market or private sale
$1,609 $2.36 p/Share
682 Reduced 2.04%
32,814 Common Stock
Aug 11 2023
BUY
Exercise of conversion of derivative security
$1,168 $0.51 p/Share
2,292 Added 6.4%
33,496 Common Stock
Jul 11 2023
SELL
Open market or private sale
$1,607 $2.34 p/Share
687 Reduced 2.15%
31,204 Common Stock
Jul 11 2023
BUY
Exercise of conversion of derivative security
$1,168 $0.51 p/Share
2,292 Added 6.71%
31,891 Common Stock
Jun 12 2023
SELL
Open market or private sale
$1,610 $2.64 p/Share
610 Reduced 2.02%
29,599 Common Stock
Jun 12 2023
BUY
Exercise of conversion of derivative security
$1,168 $0.51 p/Share
2,291 Added 7.05%
30,209 Common Stock
May 11 2023
SELL
Open market or private sale
$1,624 $2.89 p/Share
562 Reduced 1.97%
27,918 Common Stock
May 11 2023
BUY
Exercise of conversion of derivative security
$1,168 $0.51 p/Share
2,291 Added 7.45%
28,480 Common Stock
Apr 11 2023
SELL
Open market or private sale
$1,545 $1.84 p/Share
840 Reduced 3.11%
26,189 Common Stock
Apr 11 2023
BUY
Exercise of conversion of derivative security
$1,168 $0.51 p/Share
2,292 Added 7.82%
27,029 Common Stock
Mar 13 2023
SELL
Open market or private sale
$1,561 $1.75 p/Share
892 Reduced 3.48%
24,737 Common Stock
Mar 13 2023
BUY
Exercise of conversion of derivative security
$1,168 $0.51 p/Share
2,291 Added 8.21%
25,629 Common Stock
Feb 13 2023
SELL
Open market or private sale
$20,761 $2.45 p/Share
8,474 Reduced 26.64%
23,338 Common Stock
Feb 13 2023
BUY
Exercise of conversion of derivative security
$14,025 $0.51 p/Share
27,500 Added 46.36%
31,812 Common Stock
LD

Lisa Delfini

Chief Financial Officer
New Haven, CT

Track Institutional and Insider Activities on TRVI

Follow Trevi Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TRVI shares.

Notify only if

Insider Trading

Get notified when an Trevi Therapeutics, Inc. insider buys or sells TRVI shares.

Notify only if

News

Receive news related to Trevi Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TRVI